Isradipine
生产企业:Smithkline beecham corp dba glaxosmithkline, Actavis totowa llc,另有 2 家
Isradipine is a dihydropyridine calcium channel blocker used for the treatment of hypertension.
Isradipine is a dihydropyridine calcium channel blocker used for the treatment of hypertension.
Isradipine belongs to the dihydropyridine (DHP) class of calcium channel blockers (CCBs), the most widely used class of CCBs. There are at least five different types of calcium channels in Homo sapiens: L-, N-, P/Q-, R- and T-type. CCBs target L-type calcium channels, the major channel in muscle cells that mediates contraction. Similar to other DHP CCBs, isradipine binds directly to inactive calcium channels stabilizing their inactive conformation. Since arterial smooth muscle depolarizations are longer in duration than cardiac muscle depolarizations, inactive channels are more prevalent in smooth muscle cells. Alternative splicing of the alpha-1 subunit of the channel gives isradipine additional arterial selectivity. At therapeutic sub-toxic concentrations, isradipine has little effect on cardiac myocytes and conduction cells.
用于防治高血压、冠心病、心绞痛和充血性心力衰竭。
共 1 项相关疾病